What is BJDX's dilution risk score?

BJDX has a latest available DilutionScore record of 85/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BJDX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BJDX?

DilutionWatch tracks 25 SEC filing types for BJDX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BJDX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BJDX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BJDX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BJDX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BJDX Dilution Risk Score: 85/100 (component-limited)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

40

📊 Float Risk

95

⚠️ Warrant Exposure

70

🔄 Convertible Debt

85

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 48%

🔁 Convertible Conversion model 60%

• Major convertible overhang: 101% potential dilution

• Convertible risk score very high (85/100)

📜 Warrant Exercise model 40%

• Significant warrants: 24% of shares outstanding

• Elevated warrant risk score (70/100)

🔄 Reverse Split model est. 30%

• 50-day avg $1.90 approaching $1 threshold

🔔 Track BJDX — Get forecast alerts →

Market Data

Market Cap$2.21M

Shares Outstanding4.47M

Float844.5K

Cash$9.60M

DebtN/A

Short InterestN/A

Institutional Holdings

25.7% institutional ownership

Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers

🔔 Track BJDX for full holder detail →

Short Interest

Short Interest17.0K

Days to Cover1.0

% of Float2.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-04-07

xbrl XBRL CONVERTIBLE 2021-12-31

Form 4 INSIDER TRANSACTION 2026-08-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BJDX Dilution Snapshot

Bluejay Diagnostics, Inc. (BJDX) has a DilutionScore of 85/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 1.1M.
Recent SEC activity tracked for BJDX: Form 4 on 2026-08-17; Form 4 on 2026-08-17; Form 4 on 2026-08-17.
Score coverage note: Debt is unavailable or zero in the market-data feed while convertible risk is high; convertible overhang is shown separately and is not reconciled to the Debt field.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Debt is unavailable or zero in the market-data feed while convertible risk is high; convertible overhang is shown separately and is not reconciled to the Debt field.

More Research for BJDX

BJDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

BJDX — Bluejay Diagnostics, Inc. Dilution Risk Tracker